Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction—The REC-DUT-002 Trial
Dirk von Lewinski(Medical University of Graz), Markus Wallner(Medical University of Graz), Jan Debrauwere, Róbert Gábor Kiss, Andrzej Kleinrok(University of Information Technology and Management in Rzeszow), Maciej Zarębiński, Andrew J.S. Coats(The Heart Research Institute), Gergely Nagy(Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház), Hannes Alber(Klinikum Klagenfurt), Jacek Kubica(Nicolaus Copernicus University), Paweł Ptaszyński(Medical University of Lodz), Béla Merkely(Semmelweis University), Pieter C. Smits(Cardiovascular European Research Center), István Édes(University of Debrecen), Martin Benedikt(Medical University of Graz)
Cited by 3
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k